Wellington Management announced it will acquire Hartford Funds, expected to close in 2027’s first quarter, internalizing roughly USD 130 billion of the USD 1.35 trillion manager’s assets that it has long subadvised for the fund family (which holds USD 160 billion total). Hartford Funds will be rebranded as Wellington.
The Hartford Healthcare Fund Class R5 HGHTX
- NAV / 1-Day Return 47.77 / −0.13 %
- Total Assets 743.6M
-
Adj. Expense Ratio
1.060%
- Expense Ratio 1.060%
- Distribution Fee Level High
- Share Class Type Retirement, Large
- Category Health
- Investment Style Large Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 49%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:11 AM GMT+0
Morningstar’s Analysis HGHTX
Will HGHTX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the HGHTX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of HGHTX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 46.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 11.88 | 86M | Healthcare |
Merck & Co Inc | 6.32 | 46M | Healthcare |
Johnson & Johnson | 5.82 | 42M | Healthcare |
UnitedHealth Group Inc | 5.55 | 40M | Healthcare |
Intuitive Surgical Inc | 3.63 | 26M | Healthcare |
AbbVie Inc | 3.09 | 23M | Healthcare |
Abbott Laboratories | 2.80 | 20M | Healthcare |
Danaher Corp | 2.69 | 20M | Healthcare |
Edwards Lifesciences Corp | 2.55 | 19M | Healthcare |
CVS Health Corp | 2.44 | 18M | Healthcare |
United States